Search results

Two studies conducted by Epicentre support the importance of facilitating access to viral load tests and understanding the degree of resistance to antiretroviral therapy (ART) to better and more rapidly adapt treatments for people living with HIV.

In a new publication, Epicentre and partners confirm the sustained efficacy obtained with Rotasiil®, a heat-stable rotavirus vaccine, for low- and middle-income countries. Sheila Isanaka, principal investigator of the trial, tells us more about rotavirus and the importance of vaccination.

Epidemiology has shown that simplified, decentralized hepatitis C care can be integrated into public and rural health services in resource-limited settings, while maintaining high rates of patient follow-up, treatment efficacy and safety. This proof-of-concept by Médecins Sans Frontières (MSF) and Epicentre in Cambodia, where a parallel hepatitis C virus (HCV) seroprevalence study was conducted, therefore supports the extension of this model of care to other countries or regions.